BOHEMIA, N.Y., Jan. 19, 2017 -- Scientific Industries Inc. (OTCBB:SCND), announced the resignation of Roger B. Knowles, a Director of the Company and the appointment of Mr. John Watkins as his duly elected successor. Ms. Helena R. Santos, Chief Executive Officer and a Director stated that the Company was extremely grateful for Mr. Knowles’ dedicated service to the Company as a Director since 1965 and wishes him well in his retirement. Mr. Watkins is a partner with the law firm of Reitler Kailas & Rosenblatt LLC, the Company’s chief corporate counsel.
“I am delighted to announce the addition of this esteemed individual to our Board. Mr. Watkins brings years of expertise in mergers and acquisitions, venture capital, and joint venture transactions across a broad range of industries from biotechnology to manufacturing and banking, among others,” said Helena Santos.
About Scientific Industries
Scientific Industries designs, manufactures, and markets a variety of laboratory equipment, including the Genie and Torbal brand products; produces and sells customized catalyst research instruments, and the research, development and production of bioprocessing systems and methods. Scientific Industries’ products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, chemical companies, and medical device manufacturers.
“Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company’s Securities and Exchange Commission reports, including our annual report on Form 10-K.”
Phone: 888-850-6208 Fax: 631-567-5896 [email protected] www.scientificindustries.com


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Italy Fines Apple €98.6 Million Over App Store Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 



